Ibrutix 140mg Capsule 120`s

Ibrutix 140mg is a potent kinase inhibitor used to treat specific types of blood cancers and chronic graft versus host disease. This oral medication specifically targets the proteins that allow cancer cells to grow and spread in the body. Order Ibrutix capsules from PakMeds for genuine oncological medications delivered with reliable service across Pakistan.

Ibrutix Ingredients and Usage

Ibrutix contains Ibrutinib, a small-molecule drug that acts as a highly selective Bruton’s tyrosine kinase (BTK) inhibitor. Each hard capsule delivers 140mg of the active ingredient formulated for optimal oral absorption and systemic distribution. The 120-capsule pack size is designed to provide a standard monthly supply for most adult dosing regimens.

Doctors prescribe Ibrutix for patients with Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), and Mantle Cell Lymphoma (MCL). It is also an effective treatment for Waldenström’s Macroglobulinemia and chronic graft versus host disease (cGVHD) after failed systemic therapies. Patients should swallow the capsules whole with a glass of water at the same time each day.

How Does Ibrutix Work?

Ibrutix works by forming a covalent bond with a specific residue in the Bruton’s tyrosine kinase (BTK) enzyme. This enzyme is a critical component of the B-cell receptor signaling pathway, which transmits the "survive and multiply" signals to B-cells. By permanently blocking BTK, Ibrutix effectively cuts off the communication line that allows malignant B-cells to proliferate.

Beyond stopping cell growth, Ibrutix also inhibits the ability of cancer cells to adhere to and migrate within lymphoid tissues. This forces the cancerous cells out of their protective environments in the lymph nodes and into the bloodstream where they die naturally. This targeted approach spares most healthy cells, leading to a more focused treatment compared to traditional systemic chemotherapy.

Ibrutix Side Effects

Ibrutix can cause various reactions as the body adjusts to the kinase inhibition and the clearance of cancer cells. Regular monitoring of blood counts and heart rhythm is essential during the initial months of treatment.

• Diarrhoea and nausea

• Upper respiratory tract infections

• Fatigue and muscle aches

• Bruising and small red spots on the skin

• Low blood platelet counts (thrombocytopenia)

• Stomatitis or mouth sores

• Hypertension (high blood pressure)

• Peripheral edema (swelling of hands or feet)

• Rash or dry skin

• Dizziness and headache

• Anemia or shortness of breath

• Increased risk of minor bleeding

Warnings

Ibrutix may cause serious bleeding events, so patients should inform their surgeon before any planned dental or medical procedures. Atrial fibrillation and flutter have occurred in patients taking Ibrutix, requiring periodic monitoring of heart rhythm during therapy. Severe infections, including bacterial, viral, or fungal sepsis, can occur and must be treated immediately with appropriate anti-infectives.

Cytopenias, including neutropenia and anemia, are common; therefore, complete blood counts should be monitored monthly. Hypertension may develop or worsen during treatment, necessitating regular blood pressure checks and potential antihypertensive medication. Second primary malignancies, such as non-melanoma skin cancers, have been reported in patients receiving long-term Ibrutinib therapy.

Avoid consuming grapefruit or Seville oranges while taking Ibrutix, as these can significantly increase the drug levels in your blood. Pregnant women must not use Ibrutix due to the risk of fetal harm; effective contraception is required for both men and women.

Ibrutix Storage Conditions

Store Ibrutix 140mg capsules at room temperature between 20°C and 25°C in a dry place away from direct sunlight. Keep the bottle tightly closed to protect the medication from moisture and ensure the desiccant remains inside the container. Always store this medicine in a secure location out of the reach of children and domestic pets.